dexamethasone,lenalidomide,bortezomib
Takeda,Acrotech
['multiplemyeloma', 'determination', 'mmsm']
#asco22 plenary session: determination trial results show that patients w/ asct had significantly better pfs vs those who didn't, but no difference in os was observed. #hemonc #multiplemyeloma #mmsm
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ? endorse.